We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

No Correlation Between Cost of Cancer Drugs and Their Clinical Benefit

News   May 01, 2020 | Original story from the University of Zurich

 
No Correlation Between Cost of Cancer Drugs and Their Clinical Benefit
 
 
Advertisement
 

RELATED ARTICLES

Proteins in the Blood of COVID-19 Patients Could Help Predict How Ill They Will Become

News

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

READ MORE

Trial Investigates Unique Formulation of Ibuprofen as Treatment for COVID-19 Respiratory Complication

News

A trial is investigating a unique formulation of ibuprofen as a treatment for severe acute respiratory distress syndrome (ARDS), a complication of COVID-19.

READ MORE

What Are the Risks and Benefits of Low-dose Aspirin?

News

Low-dose aspirin significantly lowers cardiovascular disease risk but can increase the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE